Reversible inhibitors of tafia can both promote and inhibit fibrinolysis

Journal of Thrombosis and Haemostasis

Volumn 1, Issue 1, 2003, Pages 147-154

  Schneider, M ^a   Nesheim, M ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Clot stability; Fibrinolysis; Potato tuber carboxypeptidase inhibitor; Thrombin activable fibrinolysis inhibitor

Indexed keywords

ARGININE; DRUG DERIVATIVE; ENZYME INHIBITOR; FIBRIN; RECOMBINANT PROTEIN; THROMBIN; THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR; THROMBOMODULIN;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; BLOOD; BLOOD CLOTTING; CELL LINE; CHEMISTRY; CYTOLOGY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; FIBRINOLYSIS; HAMSTER; HUMAN; KIDNEY; KINETICS; METABOLISM; PHYSIOLOGY; POTATO;

ANIMALS; ARGININE; BLOOD COAGULATION; CARBOXYPEPTIDASE U; CELL LINE; CRICETINAE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ENZYME INHIBITORS; FIBRIN; FIBRINOLYSIS; HUMANS; KIDNEY; KINETICS; MODELS, BIOLOGICAL; RECOMBINANT PROTEINS; SOLANUM TUBEROSUM; THROMBIN; THROMBOMODULIN;

EID: 0141484363     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1046/j.1538-7836.2003.00028.x     Document Type: Article

References (16)

1. Bajzar L, Manuel R, Nesheim ME. Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor. J Biol Chem 1995; 270: 14477-84.
2. Wang W, Boffa MB, Bajzar L, Walker JB, Nesheim ME. A study of the mechanism of inhibition of fibrinolysis by activated thrombin-activable fibrinolysis inhibitor. J Biol Chem 1998; 273: 27176-81.
3. Tan AK, Eaton DL. Biochemistry. Activation and characterization of procarboxypeptidase B from human plasma. Biochemistry 1995; 34: 5811-6.
4. Wang W, Hendriks DF, Scharpe SS. Carboxypeptidase U, a plasma carboxypeptidase with high affinity for plasminogen. J Biol Chem 1994; 269: 15937-44.
5. Schneider M, Boffa M, Stewart R, Rahman M, Koschinsky M, Nesheim M. Two naturally occurring variants of TAFI (Thr-325 and Ile-325) differ substantially with respect to thermal stability and antifibrinolytic activity of the enzyme. J Biol Chem 2002; 277: 1021-30.
6. Boffa MB, Bell R, Stevens WK, Nesheim ME. Roles of thermal instability and proteolytic cleavage in regulation of activated thrombin-activable fibrinolysis inhibitor. J Biol Chem 2000; 275: 12868-78.
7. Mock WL, Xu D. Catalytic activity of carboxypeptidase B and of carboxypeptidase Y with anisylazoformyl substrates. Bioorg Med Chem Lett 1998; 9: 187-92.
8. Bajzar L, Nesheim ME, Tracy P. The profibrinolytic effect of activated protein c in clots formed from plasma is TAFI-dependent. Blood 1996; 88: 2093-100.
9. Walker JB, Nesheim ME. The molecular weights, mass distribution, chain composition, and structure of soluble fibrin degradation products released from a fibrin clot perfused with plasmin. J Biol Chem 1999; 274: 5201-12.
10. Bloom JW, NesheimME, Mann KG. Phospholipid-binding properties of bovine factor V and factor Va. Biochemistry 1979; 18: 4419-25.
11. Eaton DL, Malloy BE, Tsai SP, Henzel W, Drayna D. Isolation, molecular cloning, and partial characterization of a novel carboxypeptidase B from human plasma. J Biol Chem 1991; 266: 21833-8.
12. Boffa MB, Wang W, Bajzar L, Nesheim ME. Plasma and recombinant thrombin-activable fibrinolysis inhibitor (TAFI) and activated TAFI compared with respect to glycosylation, thrombin/thrombomodulindependent activation, thermal stability, and enzymatic properties. J Biol Chem 1998; 273: 2127-35.
13. Chen C, Okayama H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 1987; 7: 2745-52.
14. Rees DC, Lipscomb WN. Structure of the potato inhibitor complex of carboxypeptidase A at 2.5-Å resolution. Proc Natl Acad Sci USA 1980; 77: 4633-7.
15. Marx PF, Bouma BN, Meijers JC. Plasmin-mediated activation and inactivation of thrombin-activatable fibrinolysis inhibitor. Biochemistry 2002; 41: 1211-6.
16. Marx PF, Hackeng TM, Dawson PE, Griffin JH, Meijers JC, Bouma BN. Inactivation of active thrombin-activable fibrinolysis inhibitor takes place by a process that involves conformational instability rather than proteolytic cleavage. J Biol Chem 2000; 275: 12410-5.